Publication Date
2024
Journal or Book Title
Metabolites
Abstract
Engineered microorganisms such as the probiotic strain Escherichia coli Nissle 1917 (EcN) offer a strategy to sense and modulate the concentration of metabolites or therapeutics in the gastrointestinal tract. Here, we present an approach to regulate the production of the depression-associated metabolite gamma-aminobutyric acid (GABA) in EcN using genetic circuits that implement negative feedback. We engineered EcN to produce GABA by overexpressing glutamate decarboxylase and applied an intracellular GABA biosensor to identify growth conditions that improve GABA biosynthesis. We next employed characterized genetically encoded NOT gates to construct genetic circuits with layered feedback to control the rate of GABA biosynthesis and the concentration of GABA produced. Looking ahead, this approach may be utilized to design feedback control of microbial metabolite biosynthesis to achieve designable smart microbes that act as living therapeutics.
ORCID
Andrews: https://orcid.org/0000-0003-1627-1430
DOI
https://doi.org/10.3390/metabo14010044
Pages
44
Volume
14
Issue
1
License
UMass Amherst Open Access Policy
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Funder
NSF CBET-1943695, NSF MCB-2211039, NIH T32 GM135096
Recommended Citation
Lebovich, Matthew; Lora, Marcos A.; Gracia-David, Jared; and Andrews, Lauren, "Genetic Circuits for Feedback Control of Gamma-Aminobutyric Acid Biosynthesis in Probiotic Escherichia coli Nissle 1917" (2024). Metabolites. 929.
https://doi.org/10.3390/metabo14010044
Supplementary Information